Publikationen in Zusammenarbeit mit Forschern von Johns Hopkins University (43)

2024

  1. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3

2023

  1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

  2. Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide

    The Lancet Oncology, Vol. 24, Núm. 12, pp. e472-e518

  3. Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer

    Gynecologic Oncology, Vol. 170, pp. 300-308

2022

  1. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  2. Front of package labels and olive oil: a call for caution

    European Journal of Clinical Nutrition, Vol. 76, Núm. 4, pp. 502-504

  3. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies

    Gut, Vol. 71, Núm. 6, pp. 1095-1105

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

  2. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

    Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282

  3. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  4. Sex differences between women and men with COPD: A new analysis of the 3CIA study

    Respiratory Medicine, Vol. 171

2019

  1. Analysis of the ROADSTER pivotal and extended-access cohorts shows excellent 1-year durability of transcarotid stenting with dynamic flow reversal

    Journal of Vascular Surgery, Vol. 69, Núm. 6, pp. 1786-1796

  2. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  3. Visual fixation and continuous head rotations have minimal effect on set-point adaptation to magnetic vestibular stimulation

    Frontiers in Neurology, Vol. 10, Núm. JAN

2018

  1. Hospital mortality prediction for intermediate care patients: Assessing the generalizability of the Intermediate Care Unit Severity Score (IMCUSS)

    Journal of Critical Care, Vol. 46, pp. 94-98

  2. Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease

    BMC Medicine, Vol. 16, Núm. 1

  3. Olive oil and prevention of chronic diseases: Summary of an International conference

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 28, Núm. 7, pp. 649-656

2017

  1. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

    Open Heart, Vol. 4, Núm. 2

  2. Multiple Score Comparison: A network meta-analysis approach to comparison and external validation of prognostic scores

    BMC Medical Research Methodology, Vol. 17, Núm. 1